---
title: "Corbus Pharma names Nishant Saxena chief business officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287215343.md"
description: "Corbus Pharmaceuticals has appointed Nishant Saxena as its first chief business officer, advancing towards registrational-stage development for its lead programs. Saxena previously served as CFO at Jeune Aesthetics and has over 15 years of experience at Evercore, focusing on healthcare mergers and acquisitions."
datetime: "2026-05-21T12:01:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287215343.md)
  - [en](https://longbridge.com/en/news/287215343.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287215343.md)
---

# Corbus Pharma names Nishant Saxena chief business officer

-   Corbus Pharmaceuticals named Nishant Saxena as its first chief business officer as it moves toward registrational-stage development for its lead programs. \* Saxena was most recently chief financial officer at Jeune Aesthetics, a unit of Krystal Biotech. \* He previously spent more than 15 years at Evercore, most recently as a managing director in the healthcare group advising on mergers, acquisitions, financings, and partnerships. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [EVR.US](https://longbridge.com/en/quote/EVR.US.md)

## Related News & Research

- [Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital](https://longbridge.com/en/news/286648720.md)
- [RBC Capital Reaffirms Their Buy Rating on Corbus Pharmaceuticals (CRBP)](https://longbridge.com/en/news/286342985.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Brokers Offer Predictions for CRBP Q2 Earnings](https://longbridge.com/en/news/286408539.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)